Latest releases

22.01.2021

FN, GR

Herantis Pharma Strengthens Management Team with New CMO
11.01.2021

PR

Herantis Pharma Plc’s to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
23.12.2020

FN, GR

Herantis Pharma Plc’s Financial Calendar and Annual General Meeting in 2021
18.12.2020

FN, IT, PR

Herantis Pharma Oyj : Managers’ Transactions – Tone Kvåle
18.12.2020

FN, GR

Herantis Pharma Plc: 2,162,163 new shares registered with the trade register
18.12.2020

FN, GR

Herantis Pharma Plc successfully completes private placement raising EUR 8 million
17.12.2020

FN, GR

Herantis Pharma Plc launches an accelerated bookbuilding process to raise a minimum of EUR 6.5 million through a private placement of new shares
17.12.2020

FN, PR

Herantis Pharma and Nanoform Sign a Letter of Intent (LOI) for Collaboration
02.12.2020

FN, GR, PR

Decisions of Herantis Pharma Plc’s Extraordinary General Meeting of shareholders
17.11.2020

LR, PR

Herantis Pharma Announces Favorable 24-Month Follow-Up Review from Phase I Lymfactin® []Trial in Breast Cancer Associated Lymphedema

Quick links

Analyst Coverage »

Financial Calendar »

General Meetings »

Financial Information »

Share Information »

Share Monitor »

Investor Relations »

Corporate Governance »